Navigation Links
New EPA Rodent Study Finds No Low-Dose BPA Effects on Reproductive Function or Behavior
Date:10/29/2009

ARLINGTON, Va., Oct. 29 /PRNewswire-USNewswire/ -- The American Chemistry Council (ACC) today commented on a significant study funded and conducted by EPA and published online yesterday in the journal Toxicological Sciences. In this study, researchers exposed female rodents to both BPA and ethinyl estradiol (EE2)in utero in a wide range of doses to look for effects.

Quotes below may be attributed to Steven G. Hentges, Ph.D., ACC's Polycarbonate/BPA Global Group:

"This new rodent study, funded and conducted by EPA, finds that low-dose exposures of bisphenol A (BPA) showed no effects on the range of reproductive functions and behavioral activities measured. Well-conducted, peer-reviewed studies such as this provide the basis for reasoned government assessments and regulatory decisions.

"Eleven regulatory agencies from around the world have concluded that science supports the safety of BPA for people of all ages in its current uses. The results of this new study provide further strong support for those conclusions. Plastics made with BPA contribute to the safety and convenience of everyday life because of their durability, clarity and shatter-resistance. Can liners made with BPA are essential components to protecting the safety of packaged foods and preserving products from spoilage and contamination.

"These areas of scientific interest were identified as needing further research in a 2008 report on BPA from the National Toxicology Program. This EPA-funded, well-conducted study is a significant development in better understanding the safety of BPA. Sound scientific review must be the foundation of decisions concerning the government's current and future regulatory process, as chemical management reform is considered."

Background on the study

The study conclusion states: "The lack of effect of BPA on female and male rat offspring after or
'/>"/>

SOURCE American Chemistry Council
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. New Report Finds U.S. Cities More Vulnerable Than Ever to Rodent Infestation
2. Stress hormone impacts memory, learning in diabetic rodents
3. Rodent study finds artificial butter chemical harmful to lungs
4. Improved rodent trials can speed cancer drug development
5. Turmeric extract suppresses fat tissue growth in rodent models
6. New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents
7. Penn study finds pro-death proteins required to regulate healthy immune function
8. New study shows promise in reducing surgical risks associated with surgical bleeding
9. Study, meta-analysis examine factors associated with death from heatstroke
10. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
11. Study says COPD testing is not measuring up
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 2015 The Maricopa Community Colleges ... to the Arizona economy each year, according to a ... Economic Value of Maricopa County Community College District, summarizes ... district in fiscal year 2013-2014. , The analysis ... (EMSI), an organization that specializes in providing economic impact ...
(Date:3/5/2015)... SuperCloset has released a new video series called ... viewers everything they need to know about how to grow ... you from seed all the way through harvest, and covers ... prune Grow Like a SuperPro will help take the guesswork ... download for a special introductory price of $19.95. Or you ...
(Date:3/5/2015)... 2015 TCS Healthcare Technologies (TCS), a ... population health management arena, is pleased to announce a ... ACUITY Advanced Care™ (ACUITY) version 7.20. The session will ... the advantages of automation. , The webinar, scheduled for ... led by Jeff Frater, RN, BSN, Director of Partner ...
(Date:3/5/2015)... PA (PRWEB) March 05, 2015 ... leader in healthcare communications and education, announced today ... (AMP), the nation’s only medical conference designed ... limb ischemia and lower limb amputation due to ... growing family of innovative, evidence-based publications and CME ...
(Date:3/5/2015)... 05, 2015 Califia Farms , ... the natural products coffee drinks category[1], today unveils its ... West in Anaheim, Calif. Concentrated Cold Brew (CCB) ... Café, which democratizes the next wave of the coffee-taste ... need to become their own baristas. , Califia ...
Breaking Medicine News(10 mins):Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 2Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 3Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 3Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4
... , , NAPLES, Fla., Sept. 3 ... the elderly and is projected to increase in prevalence over the ... for treatments that will prevent or reverse the now-inexorable course of ... expensive and complex, many researchers are focusing on botanical extracts whose ...
... To avoid injuries, watch backpack weight and fit, expert suggests, ... be a great help to school children, but it needs ... professionals say. , "If too heavy or worn incorrectly, ... pain," Paula Kramer, who chairs the occupational therapy department at ...
... , FRANKLIN, Mass., Sept. 3 ... ECTE), a diabetes management company developing the ... continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep ... that Patrick T. Mooney, M.D., Chairman and Chief Executive ...
... HARBIN, China, Sept. 3 /PRNewswire-Asia-FirstCall/ -- China Sky ... (Nasdaq: CSKI ), a,leading fully integrated pharmaceutical ... ("PRC"), today announced that the,Company has finished the required ... submitted application to the State Food and Drug Administration,(SFDA) ...
... MOUNTAIN VIEW, Calif., Sept. 3 An expanding ... the U.S. bone and joint health ingredients market. Consumers ... wellness quotient and have strong scientific backup. The rise ... need for well-researched ingredients that deliver tangible advantages. , ...
... , , CARLSBAD, Calif., ... leader in antisense therapeutics, today announced that management will present a company ... 9, 2009, at 11:30 a.m. ET at the Boston Four Seasons Hotel. ... will be available on the "Investors & Media" section of the Company,s ...
Cached Medicine News:Health News:HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid-Beta Accumulation, a Hallmark of Alzheimer's Disease 2Health News:HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid-Beta Accumulation, a Hallmark of Alzheimer's Disease 3Health News:Take the Load Off Your Child's Back 2Health News:Echo Therapeutics to Present at Rodman & Renshaw 2009 Annual Global Investment Conference 2Health News:China Sky One Medical, Inc. Submits Application to Perform Clinical Trials for Two New Eye Drugs to SFDA 2Health News:China Sky One Medical, Inc. Submits Application to Perform Clinical Trials for Two New Eye Drugs to SFDA 3Health News:Aging Population, Heightened Consumer Awareness Propel U.S. Bone and Joint Health Ingredients, Says Frost & Sullivan 2Health News:Aging Population, Heightened Consumer Awareness Propel U.S. Bone and Joint Health Ingredients, Says Frost & Sullivan 3Health News:Aging Population, Heightened Consumer Awareness Propel U.S. Bone and Joint Health Ingredients, Says Frost & Sullivan 4Health News:Isis Pharmaceuticals to Present at Thomas Weisel Partners' Healthcare Conference 2009 2
(Date:3/5/2015)... , March 5, 2015 ... pressphoto agency ( http://www.epa.eu ) - ... lancio della nuova generazione di OASIS* all,ECR 2015. Si ... ad alto campo da 1.2 T che migliora la ... nuovo traguardo nell,attenzione al comfort del paziente. Le nuove ...
(Date:3/5/2015)... DUBLIN and HAMPTON, N.J. ... (NYSE: MNK ), a leading global ... care company, announced today that they have entered into ... will acquire Ikaria, Inc. from a Madison Dearborn ... $2.3 billion. Subject to customary closing ...
(Date:3/5/2015)...  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading ... announced today that Atlanta -based Shepherd ... spinal cord injury and brain injury, has commenced enrollment ... progenitor cells) in newly injured patients with sensory and ... The Phase 1/2a trial follows the successful completion ...
Breaking Medicine Technology:Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 2Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 3Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4
Used in conjunction with the E5381 600 Circling Band (40 style). Indications: Narrow scleral bed. Overall length: 100 mm, 3.9 inches....
...
...
...
Medicine Products: